Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis

被引:16
作者
Al Durahim, H. [2 ]
Al Ghamdi, G. [2 ]
Al Seraya, A. [2 ]
Alkhiari, R. [2 ]
Al Sayyari, A. [1 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh 11426, Saudi Arabia
[2] Dept Med, King Abdulaziz Med City, Saudi Arabia
关键词
lupus nephritis; Saudi Arabia; SLE; ERYTHEMATOSUS; ARABIA; CLASSIFICATION; MANIFESTATIONS; PREVALENCE; OUTCOMES; PROFILE; COHORT;
D O I
10.1177/0961203311415560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to investigate the presentation and factors affecting outcome over a 9-year period in 99 consecutive Saudi patients with biopsy proven lupus nephritis (LN), 35.5% of whom had nephrotic range proteinuria, 46.8% had estimated glomerular filtration rate (eGFR) <60 ml/min/1.73m(2) and 65.5% had histological class IV. The female:male ratio was 3.7:1. During the observation period, there were significant rises in eGFR (p = 0.005), C4 (p = 0.000) and significant decrease in 24-h urine protein (p = 0.028). No correlation was found between final eGFR and baseline 24-h protein, anti-DNA, C3 or C4. Female patients had a significantly higher rise in eGFR (p = 0.05). During follow-up (FU), 28.2% required dialysis. The survival rates at 5, 10 and 15 years were 92%, 77% and 77% respectively. Baseline C3 and C4 levels were significantly lower in the patients who died (p = 0.0001 and 0.02 respectively). Those who required dialysis were more likely to die (p < 0.000) (risk ratio = 4.46; 95% confidence interval 2.8-7.2). Hypertension at presentation was associated with lower baseline eGFR (p = 0.01) and final eGFR (p = 0.002) but did not affect the baseline proteinuria. Baseline eGFR of <60 ml/min/1.73m(2) at presentation was associated with lower eGFR at end of FU (p = 0.000), higher activity score (p = 0.0001) and chronicity scores (p = 0.017). Lupus (2011) 20, 1329-1335.
引用
收藏
页码:1329 / 1335
页数:7
相关论文
共 34 条
[1]   Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia [J].
Al Arfaj, A. S. ;
Khalil, N. .
LUPUS, 2009, 18 (05) :465-473
[2]  
Al-Arfaj AS, 2002, SAUDI MED J, V23, P87
[3]   Systemic lupus erythematosus and infections: a retrospective study in Saudis [J].
Al-Rayes, H. ;
M-Swailem, R. ;
Arfin, M. ;
Sobkil, S. ;
Rizvil, S. ;
Tariq, M. .
LUPUS, 2007, 16 (09) :755-763
[4]  
Al-Zahrani IH, 2007, SAUDI MED J, V28, P1503
[5]  
Alarcón GS, 2001, ARTHRIT RHEUM-ARTHR, V45, P191, DOI 10.1002/1529-0131(200104)45:2<191::AID-ANR173>3.0.CO
[6]  
2-2
[7]   Baseline characteristics of a multiethnic lupus cohort:: PROFILE [J].
Alarcón, GS ;
McGwin, G ;
Petri, M ;
Reveille, JD ;
Ramsey-Goldman, R ;
Kimberly, RP .
LUPUS, 2002, 11 (02) :95-101
[8]  
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[9]   Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity [J].
Barr, RG ;
Seliger, S ;
Appel, GB ;
Zuniga, R ;
D'Agati, V ;
Salmon, J ;
Radhakrishnan, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :2039-2046
[10]   CLINICAL AND AUTOANTIBODY CORRELATIONS IN ORIENTALS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BOEY, ML ;
PEEBLES, CL ;
TSAY, G ;
FENG, PH ;
TAN, EM .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (11) :918-923